title: Report from the Melanoma Independent Board First Melanoma MIB Conference, 21-22 October 2013.
abstract: The Melanoma Independent Board (MIB) held its first conference from 21 to 22 October, 2013, in Rome, Italy. Like the MIB itself, the conference brought together specialists from all aspects of cancer care: doctors, patient associations, journalists, and representatives from local government, hospitals, and pharma to encourage an interdisciplinary discussion on the future of melanoma. It was hoped that the conference would be an opportunity for all participants to see and understand each other's points of view. In memoriam of melanoma pioneer Natalie Cascinelli, the conference focussed on innovation and sustainability as well as the latest drug developments.
authors: European Institute of Oncology, Via Ripamonti 435, Milan 20141, Italy.
authors: A
authors: A
authors: Testori
authors: Istituto Nazionale dei Tumori di Napoli, Italy.
authors: P
authors: P
authors: Ascierto
authors: Istituto Oncologico Veneto, Padova, Italy.
authors: V
authors: V
authors: Chiarion Sileni
authors: Federazione Italiana delle Associazioni di Volontariato in Oncologia, Italy.
authors: F
authors: F
authors: De Lorenzo
authors: European Institute of Oncology, Via Ripamonti 435, Milan 20141, Italy.
authors: Pg
authors: P
authors: Pelicci
authors: Istituto Oncologico Veneto, Padova, Italy.
authors: Cr
authors: C
authors: Rossi
keywords: cost-effective treatment; melanoma; new therapies; treatment guidelines